TYROSINE KINASE INHIBITORS AND INTERFERON
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was considered as a breakthrough in the therapy of this disease; INF administered alone or in combination with aracytine was the standard choice for treatment for Chronic Myeloid Leukemia (CML) patients unfi...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2014-01-01
|
| Edice: | Mediterranean Journal of Hematology and Infectious Diseases |
| Témata: | |
| On-line přístup: | http://www.mjhid.org/index.php/mjhid/article/view/1359 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|